MICA™ Test by Clear Gene
What is the MICA™ Test?
MICA is intended for the qualitative detection of SARS-CoV-2 nucleic acid in upper respiratory samples from individuals suspected of COVID-19 by a healthcare provider. MICA is only for use under the U.S. Food and Drug Administration’s Emergency Use Authorization.
Which organization can run the MICA™ Test?
Testing is limited to laboratories certified under the Clinical Laboratory Improvement
Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high
complexity tests. The MICA Test and MICA Software are intended for use by qualified laboratory personnel specifically instructed and trained in general PCR and in vitro diagnostic procedures.
Interested in learning more?
Download the Instructions for Users on the Support Page